Skip to main content
SpringerLink
Log in

Dasabuvir/ombitasvir/paritaprevir/ritonavir

Development of ombitasvir resistance in hepatitis C virus infection leading to real-life 3D therapy failure: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Marascio N, et al. Real-life 3D therapy failure: Analysis of NS5A 93H RAS plus 108 K polymorphism in complex with ombitasvir by molecular modeling. Journal of Medical Virology 90: 1257-1263, No. 7, Jul 2018. Available from: URL: http://doi.org/10.1002/jmv.25073- Italy

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dasabuvir/ombitasvir/paritaprevir/ritonavir. Reactions Weekly 1710, 112 (2018). https://doi.org/10.1007/s40278-018-48785-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-48785-9

Search

Navigation